Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study

被引：0

作者：

Vieito Villar, M. ^{[1
]}

Sepulveda Sanchez, J. M. ^{[2
]}

Moreno Garcia, V. ^{[3
]}

Lombardi, G. ^{[4
]}

Stradella, A. ^{[5
]}

Dahlrot, R. H. ^{[6
]}

Haslund, C. A. ^{[7
,8
]}

Geurts, M. ^{[9
]}

Pineda, E. ^{[10
]}

Brandal, P. ^{[11
]}

De Vos, F. Y. F. L. ^{[12
]}

Vaz Salgado, M. A. ^{[13
]}

Martinez Garcia, M. ^{[14
]}

Macchini, M. ^{[15
]}

Amoroso, B. ^{[16
]}

Sanchez, T. ^{[16
]}

Hanna, B. ^{[17
]}

Li, X. ^{[17
]}

Nikolova, Z. ^{[16
]}

Simonelli, M. ^{[18
,19
]}

机构：

[1] Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain

[2] Hosp Univ 12 Octubre, Med Oncol, Madrid, Spain

[3] Hosp Univ Fdn Jimenez Diaz, START Madrid FJD, Madrid, Spain

[4] IOV IRCCS, Ist Oncol Veneto, Dept Oncol, Oncol 1, Padua, Italy

[5] Inst Catala Oncol, Dept Med Oncol, Barcelona, Spain

[6] Odense Univ Hosp, Dept Oncol, Odense, Denmark

[7] Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark

[8] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark

[9] Erasmus MC Canc Inst, Dept Neurol, Rotterdam, Netherlands

[10] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[11] Oslo Univ Hosp, Dept Oncol, Oslo, Norway

[12] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands

[13] Hosp Univ Ramon y Cajal, Dept Med Oncol, Madrid, Spain

[14] Hosp del Mar, Dept Med Oncol, Barcelona, Spain

[15] IRCCS San Raffaele Sci Inst, Med Oncol, Milan, Italy

[16] Ctr Innovat & Translat Res Europe, Early Clin Dev, Seville, Spain

[17] Bristol Myers Squibb, Clin Pharmacol, Princeton, NJ USA

[18] Humanitas Univ, IRCCS Humanitas Res Hosp, Dept Hematol & Oncol, Milan, Italy

[19] Humanitas Univ, Dept Biomed Sci, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1694

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

500O

引用

页码：S392 / S392

页数：1

共 50 条

[1] Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
Vieito, Maria
Simonelli, Matteo
de Vos, Filip
Moreno, Victor
Geurts, Marjolein
Lorenzi, Elena
Macchini, Marina
van den Bent, Martin J.
Del Conte, Gianluca
de Jonge, Maja
Martin-Soberon, Maria Cruz
Amoroso, Barbara
Sanchez-Perez, Tania
Zuraek, Marlene
Hanna, Bishoy
Aronchik, Ida
Filvaroff, Ellen
Chang, Henry
Mendez, Cristina
Arias Parro, Marina
Wei, Xin
Nikolova, Zariana
Sepulveda, Juan Manuel
NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
[2] TROTABRESIB (CC-90010) IN COMBINATION WITH CONCOMITANT TEMOZOLOMIDE PLUS RADIOTHERAPY AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: UPDATED RESULTS FROM A PHASE 1B/2 STUDY
Vieito, Maria
Sepulveda, Juan Manuel
Moreno, Victor
de Vos, Filip
Geurts, Marjolein
Lorenzi, Elena
Macchini, Marina
van den Bent, Martin
Del Conte, Gianluca
Martin-Soberon, Maria Cruz
Brandal, Petter
Martinez Garcia, Maria
Amoroso, Barbara
Sanchez-Perez, Tania
Zuraek, Marlene
Hanna, Bishoy
Filvaroff, Ellen
Chang, Henry
Parro, Marina Arias
Wei, Xin
Liu, Yu
Nikolova, Zariana
Simonelli, Matteo
NEURO-ONCOLOGY, 2022, 24 : 75 - 75
[3] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
Omuro, Antonio Marcilio Padula
Beal, Kathryn
McNeill, Katharine Anne
Thomas, Alissa A.
Lin, Xuling
Kaley, Thomas Joseph
DeAngelis, Lisa Marie
Mellinghoff, Ingo K.
Diamond, Eli L.
Chan, Timothy An-thy
Young, Robert J.
Yamada, Yoshiya
Gorman, Greg
Lamson, Michael
Bavisotto, Linda M.
Karmali, Rashida A.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[4] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
Thomas, Alissa A.
Beal, Kathryn
McNeill, Katharine Anne
Kaley, Thomas Joseph
DeAngelis, Lisa Marie
Mellinghoff, Ingo K.
Diamond, Eli L.
Chan, Timothy An-thy
Young, Robert J.
Perez, Julio Arevalo
Yamada, Yoshiya
Anderson, Barry Douglas
Lamson, Michael
Burch, Brandon
Karmali, Rashida A.
Omuro, Antonio Marcilio Padula
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[5] Phase I study of afatinib and radiotherapy (RT) with or without temozolomide (TMZ) in newly diagnosed glioblastoma (GB).
Saran, Frank
Welsh, Liam
James, Allan
McBain, Catherine
Gattamaneni, Rao
Jefferies, Sarah
Harris, Fiona
Cseh, Agnieszka
Pemberton, Karine
Schaible, Jennifer
Bender, Shaun
Brada, Michael
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[6] Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study
Athanassiou, H
Synodinou, M
Maragoudakis, E
Paraskevaidis, M
Verigos, C
Misailidou, D
Antonadou, D
Sarris, G
Beroukas, K
Karageorgis, P
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S162 - S163
[7] Nivolumab (nivo) in combination with radiotherapy (RT) ± temozolomide (TMZ): Updated safety results from CheckMate 143 in pts with methylated or unmethylated newly diagnosed glioblastoma (GBM)
Lim, M.
Omuro, A.
Vlahovic, G.
Reardon, D. A.
Sahebjam, S.
Cloughesy, T.
Baehring, J.
Butowski, N.
Potter, V.
Zwirtes, R.
Paliwal, P.
Carleton, M.
Sampson, J.
Brandes, A. A.
ANNALS OF ONCOLOGY, 2017, 28
[8] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Saran, Frank
James, Allan
McBain, Catherine
Jefferies, Sarah
Harris, Fiona
Cseh, Agnieszka
Pemberton, Karine
Schaible, Jennifer
Bender, Shaun
Brada, Michael
NEURO-ONCOLOGY, 2018, 20 : 20 - 20
[9] PHASE 2 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) PLUS RADIATION THERAPY (RT) PLUS TEMOZOLAMIDE (TMZ) COMPARED TO RT PLUS TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
Grossman, Rachel
Limon, Dror
Bokstein, Felix
Ben Harosh, Carmit
Blumenthal, Deborah
Ram, Zvi
NEURO-ONCOLOGY, 2020, 22 : 196 - 196
[10] Prospective, multicentric cohort study of surgery and radiotherapy with concomitant and adjuvant chemotherapy (temozolomide: TMZ) for patients with newly diagnosed and glioblastoma multiforme.
Stummer, W.
Meinel, T.
Martus, P.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)

← 1 2 3 4 5 →